175 related articles for article (PubMed ID: 17880000)
41. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
Gourin CG; Zhi W; Adam BL
Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
[TBL] [Abstract][Full Text] [Related]
42. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
43. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
[TBL] [Abstract][Full Text] [Related]
44. Classification of breast cancer versus normal samples from mass spectrometry profiles using linear discriminant analysis of important features selected by random forest.
Datta S
Stat Appl Genet Mol Biol; 2008; 7(2):Article7. PubMed ID: 18312221
[TBL] [Abstract][Full Text] [Related]
45. Detection of papillary thyroid carcinoma with serum protein profile analysis.
Moretz WH; Gourin CG; Terris DJ; Xia ZS; Liu Z; Weinberger PM; Chin E; Adam BL
Arch Otolaryngol Head Neck Surg; 2008 Feb; 134(2):198-202. PubMed ID: 18283164
[TBL] [Abstract][Full Text] [Related]
46. Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.
Lo LH; Huang TL; Shiea J
Rapid Commun Mass Spectrom; 2009 Mar; 23(5):589-98. PubMed ID: 19165777
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
48. Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS.
Li YZ; Hu CJ; Leng XM; Zhao GF; Li N; Xu Y
Anat Rec (Hoboken); 2009 Mar; 292(3):455-60. PubMed ID: 19248174
[TBL] [Abstract][Full Text] [Related]
49. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
50. Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid.
MacGregor G; Gray RD; Hilliard TN; Imrie M; Boyd AC; Alton EW; Bush A; Davies JC; Innes JA; Porteous DJ; Greening AP
J Cyst Fibros; 2008 Sep; 7(5):352-8. PubMed ID: 18243068
[TBL] [Abstract][Full Text] [Related]
51. Short monolithic columns for purification and fractionation of peptide samples for matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry analysis in proteomics.
Moravcová D; Kahle V; Rehulková H; Chmelík J; Rehulka P
J Chromatogr A; 2009 Apr; 1216(17):3629-36. PubMed ID: 19217112
[TBL] [Abstract][Full Text] [Related]
52. Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing lung cancer patients from healthy people.
Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Chen GA; He DC
Chin Med J (Engl); 2005 Jun; 118(12):1036-9. PubMed ID: 15978214
[No Abstract] [Full Text] [Related]
53. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
[TBL] [Abstract][Full Text] [Related]
54. Perspectives for imaging mass spectrometry in the proteomics landscape.
MacAleese L; Stauber J; Heeren RM
Proteomics; 2009 Feb; 9(4):819-34. PubMed ID: 19212956
[TBL] [Abstract][Full Text] [Related]
55. Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS.
Zhang X; Guo T; Wang H; He W; Mei H; Hong M; Yu J; Hu Y; Song S
Am J Clin Pathol; 2008 Aug; 130(2):299-304. PubMed ID: 18628101
[TBL] [Abstract][Full Text] [Related]
56. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
57. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
58. [Present possibilities and future development of clinical proteomics].
Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
[TBL] [Abstract][Full Text] [Related]
59. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
Huang Z; Shi Y; Cai B; Wang L; Wu Y; Ying B; Qin L; Hu C; Li Y
Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
[TBL] [Abstract][Full Text] [Related]
60. Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.
Meuwis MA; Fillet M; Lutteri L; Marée R; Geurts P; de Seny D; Malaise M; Chapelle JP; Wehenkel L; Belaiche J; Merville MP; Louis E
Clin Biochem; 2008 Aug; 41(12):960-7. PubMed ID: 18489908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
